Cargando…
Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity
Despite the advent of effective, curative treatments for hepatitis C virus (HCV), a preventative vaccine remains essential for the global elimination of HCV. It is now clear that the induction of broadly neutralising antibodies (bNAbs) is essential for the rational design of such a vaccine. This rev...
Autores principales: | Brasher, Nicholas A., Adhikari, Anurag, Lloyd, Andrew R., Tedla, Nicodemus, Bull, Rowena A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229270/ https://www.ncbi.nlm.nih.gov/pubmed/34070572 http://dx.doi.org/10.3390/v13060983 |
Ejemplares similares
-
Broad TCR Repertoire And Diverse Structural Solutions To Recognition Of An Immunodominant CD8 T Cell Epitope
por: Song, InYoung, et al.
Publicado: (2017) -
Cross‐reactivity of hepatitis C virus specific vaccine‐induced T cells at immunodominant epitopes
por: Kelly, Christabel, et al.
Publicado: (2014) -
Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021) -
Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies
por: Walker, Melanie R., et al.
Publicado: (2019) -
Mapping Immunodominant Antibody Epitopes of Abrin
por: Alcalay, Ron, et al.
Publicado: (2020)